NFE2L2 and lung carcinoma: In this study we have used two lung cancer cell lines: adenocarcinomic human alveolar basal epithelial cells A549 and a squamous cell carcinoma RERF-LC-AI (further referred as RERF) that differ in the Nrf2 level and activation status.